MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression
Authors
Keywords
-
Journal
FEBS Journal
Volume -, Issue -, Pages n/a-n/a
Publisher
Wiley
Online
2012-11-24
DOI
10.1111/febs.12074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase 7
- (2012) Rui-Qing Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma
- (2011) Nannan Wu et al. FEBS Journal
- Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells
- (2011) Ran Qiang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans
- (2011) Pai-Sheng Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
- (2011) I Keklikoglou et al. ONCOGENE
- Identification of miRNAs that are associated with tumor metastasis in Neuroblastoma
- (2010) Jigang Guo et al. CANCER BIOLOGY & THERAPY
- Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis
- (2010) Qian Dong et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Dysregulation of miR-15a and miR-214 in human pancreatic cancer
- (2010) Xing J Zhang et al. Journal of Hematology & Oncology
- Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma
- (2010) Hai-Ying Wan et al. Molecular Cancer
- The β1-Integrin–Dependent Function of RECK in Physiologic and Tumor Angiogenesis
- (2010) Takao Miki et al. MOLECULAR CANCER RESEARCH
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Expression of RECK and matrix metalloproteinase-2 in ameloblastoma
- (2009) Bin Zhang et al. BMC CANCER
- RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription
- (2009) Satoshi Takagi et al. CANCER RESEARCH
- miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer
- (2009) Nora Bandi et al. CANCER RESEARCH
- MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1
- (2009) Li-Min Guo et al. FEBS Journal
- The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cellsin vitroandin vivo
- (2009) Chong-Keng Chang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
- (2008) G. Gabriely et al. MOLECULAR AND CELLULAR BIOLOGY
- The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
- (2008) Désirée Bonci et al. NATURE MEDICINE
- Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth
- (2008) Xiaohong Wang et al. PLoS One
- MiR-15a and miR-16-1 cluster functions in human leukemia
- (2008) George A. Calin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started